market access

Thought Leader Select Sponsors Canadian Healthcare Licensing Association Summer Meeting

Thought Leader Select sponsored last week’s summer meeting of a leading North American life sciences trade group, the Canadian Healthcare Licensing Association (CHLA). The CHLA’s summer meeting took place June 4-6 at the Queen’s Landing Resort in Niagara-on-the-Lake, Ontario, bringing together dozens of leaders in marketing, reimbursement, and business development from leading global biopharmaceutical firms …

Thought Leader Select Sponsors Canadian Healthcare Licensing Association Summer Meeting Read More »

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections

December 10, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned a new client engagement to support key opinion leader (KOL) strategies for new treatments in the area of bacterial infections. The client company, an industry leader in the development of medications to treat various bacterial infections, tabbed …

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections Read More »

Thought Leader Select Begins All-in-One Research Assessment in Support of New Dermatology Medication

March 23, 2011 (CHAPEL HILL, NC)—Thought Leader Select, a research and consulting firm focused on healthcare and the biopharmaceutical industry, has initiated its most comprehensive package of research assessments in support of a new dermatology medication for a global pharmaceutical company. The Research Triangle, NC-based firm packaged together a host of its competitive services for …

Thought Leader Select Begins All-in-One Research Assessment in Support of New Dermatology Medication Read More »

Press Release: Top 10 Global Pharmaceutical Company Chooses Thought Leader Select for US Market Access KOL Assessment

November 16, 2010 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina firm dedicated to delivering the most accurate and effective key opinion leader (KOL) profiling research for the biopharmaceutical industry, announces the launch of a drug reimbursement project for a top-10 US pharmaceutical company. With a new drug for treating coagulation coming to the market …

Press Release: Top 10 Global Pharmaceutical Company Chooses Thought Leader Select for US Market Access KOL Assessment Read More »